• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算模拟 HIV-2 糖蛋白 gp125 的 V3 区。

Computational Modulation of the V3 Region of Glycoprotein gp125 of HIV-2.

机构信息

Department of Pharmaceutical Sciences and Medicines and Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal.

Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz, Monte de Caparica, 2829-511 Caparica, Portugal.

出版信息

Int J Mol Sci. 2021 Feb 16;22(4):1948. doi: 10.3390/ijms22041948.

DOI:10.3390/ijms22041948
PMID:33669351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7920276/
Abstract

HIV-2 infection is frequently neglected in HIV/AIDS campaigns. However, a special emphasis must be given to HIV-2 as an untreated infection that also leads to AIDS and death, and for which the efficacy of most available drugs is limited against HIV-2. HIV envelope glycoproteins mediate binding to the receptor CD4 and co-receptors at the surface of the target cell, enabling fusion with the cell membrane and viral entry. Here, we developed and optimized a computer-assisted drug design approach of an important HIV-2 glycoprotein that allows us to explore and gain further insights at the molecular level into protein structures and interactions crucial for the inhibition of HIV-2 cell entry. The 3D structure of a key HIV-2ROD gp125 region was generated by a homology modeling campaign. To disclose the importance of the main structural features and compare them with experimental results, 3D-models of six mutants were also generated. These mutations revealed the selective impact on the behavior of the protein. Furthermore, molecular dynamics simulations were performed to optimize the models, and the dynamic behavior was tackled to account for structure flexibility and interactions network formation. Structurally, the mutations studied lead to a loss of aromatic features, which is very important for the establishment of π-π interactions and could induce a structural preference by a specific coreceptor. These new insights into the structure-function relationship of HIV-2 gp125 V3 and surrounding regions will help in the design of better models and the design of new small molecules capable to inhibit the attachment and binding of HIV with host cells.

摘要

HIV-2 感染在 HIV/AIDS 防治活动中经常被忽视。然而,必须特别重视未经治疗的 HIV-2 感染,因为它也会导致艾滋病和死亡,而且大多数现有药物对 HIV-2 的疗效有限。HIV 包膜糖蛋白介导与靶细胞表面受体 CD4 和共受体的结合,从而实现与细胞膜融合和病毒进入。在这里,我们开发并优化了一种重要的 HIV-2 糖蛋白的计算机辅助药物设计方法,使我们能够在分子水平上探索和进一步了解对抑制 HIV-2 细胞进入至关重要的蛋白质结构和相互作用。通过同源建模活动生成了关键的 HIV-2ROD gp125 区域的 3D 结构。为了揭示主要结构特征的重要性,并将其与实验结果进行比较,还生成了六个突变体的 3D 模型。这些突变揭示了对蛋白质行为的选择性影响。此外,还进行了分子动力学模拟以优化模型,并解决了动力学行为以解释结构灵活性和相互作用网络的形成。从结构上看,研究中的突变导致芳香特征的丧失,这对于建立 π-π 相互作用非常重要,并且可能诱导特定共受体的结构偏好。这些对 HIV-2 gp125 V3 及其周围区域结构-功能关系的新见解将有助于设计更好的模型和设计新的小分子,以抑制 HIV 与宿主细胞的附着和结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/37fb5ee6d0e8/ijms-22-01948-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/d55686273258/ijms-22-01948-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/0eff38d35b60/ijms-22-01948-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/a7b57fd657f4/ijms-22-01948-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/777161c1d2b8/ijms-22-01948-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/1bd06f2e9e17/ijms-22-01948-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/11e1479e35bc/ijms-22-01948-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/127d8b9f4731/ijms-22-01948-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/540eae2feb83/ijms-22-01948-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/37fb5ee6d0e8/ijms-22-01948-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/d55686273258/ijms-22-01948-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/0eff38d35b60/ijms-22-01948-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/a7b57fd657f4/ijms-22-01948-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/777161c1d2b8/ijms-22-01948-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/1bd06f2e9e17/ijms-22-01948-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/11e1479e35bc/ijms-22-01948-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/127d8b9f4731/ijms-22-01948-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/540eae2feb83/ijms-22-01948-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc66/7920276/37fb5ee6d0e8/ijms-22-01948-g009.jpg

相似文献

1
Computational Modulation of the V3 Region of Glycoprotein gp125 of HIV-2.计算模拟 HIV-2 糖蛋白 gp125 的 V3 区。
Int J Mol Sci. 2021 Feb 16;22(4):1948. doi: 10.3390/ijms22041948.
2
Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.CD4模拟化合物对原代人免疫缺陷病毒包膜糖蛋白三聚体的激活与失活作用
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01880-16. Print 2017 Feb 1.
3
Deletion of the V1/V2 region does not increase the accessibility of the V3 region of recombinant gp125.V1/V2区域的缺失不会增加重组gp125的V3区域的可及性。
Curr HIV Res. 2006 Apr;4(2):229-37. doi: 10.2174/157016206776055066.
4
Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.缺乏V3环的2型人类免疫缺陷病毒的复制能力变体对趋化因子受体拮抗剂表现出抗性。
J Virol. 2007 Sep;81(18):9956-66. doi: 10.1128/JVI.00385-07. Epub 2007 Jul 3.
5
CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.CD4-gp120 相互作用界面 - 人类中 HIV-1 感染的门户:分子网络、建模和对接研究。
J Biomol Struct Dyn. 2017 Sep;35(12):2631-2644. doi: 10.1080/07391102.2016.1227722. Epub 2016 Sep 29.
6
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.基于结构的HIV-1进入的CD4模拟小分子抑制剂的设计、合成及验证:从病毒进入激动剂到拮抗剂的转变
Acc Chem Res. 2014 Apr 15;47(4):1228-37. doi: 10.1021/ar4002735. Epub 2014 Feb 6.
7
Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.HIV-1 A亚型V3环的计算模型:基于结构的抗艾滋病药物设计中的构象流动性研究
J Biomol Struct Dyn. 2009 Oct;27(2):179-93. doi: 10.1080/07391102.2009.10507308.
8
Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.酪氨酸硫酸化的V2肽通过共受体模拟抑制HIV-1感染。
EBioMedicine. 2016 Aug;10:45-54. doi: 10.1016/j.ebiom.2016.06.037. Epub 2016 Jun 26.
9
Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.1型和2型人类免疫缺陷病毒以及猿猴免疫缺陷病毒的包膜糖蛋白可将人类CCR5用作病毒进入的共受体,并与这种趋化因子受体进行直接的CD4依赖性相互作用。
J Virol. 1997 Sep;71(9):6296-304. doi: 10.1128/JVI.71.9.6296-6304.1997.
10
In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.计算机模拟鉴定新型芳香族化合物作为潜在的 HIV-1 进入抑制剂模拟细胞受体 CD4。
Viruses. 2019 Aug 13;11(8):746. doi: 10.3390/v11080746.

引用本文的文献

1
Structural Modeling of Human Immunodeficiency Virus Proteins.人类免疫缺陷病毒蛋白的结构建模
Biomed Eng Comput Biol. 2023 Feb 16;14:11795972231154402. doi: 10.1177/11795972231154402. eCollection 2023.
2
HIV-2 Neutralization Sensitivity in Relation to Co-Receptor Entry Pathways and Env Motifs.HIV-2 中和敏感性与共受体进入途径和Env 基序有关。
Int J Mol Sci. 2022 Apr 26;23(9):4766. doi: 10.3390/ijms23094766.

本文引用的文献

1
Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.人类免疫缺陷病毒 2 型中抗逆转录病毒选择突变的扩展谱。
J Infect Dis. 2020 Jun 11;221(12):1962-1972. doi: 10.1093/infdis/jiaa026.
2
Molecular Mechanism of HIV-1 Entry.HIV-1 进入的分子机制。
Trends Microbiol. 2019 Oct;27(10):878-891. doi: 10.1016/j.tim.2019.06.002. Epub 2019 Jun 28.
3
Can Predicted Protein 3D Structures Provide Reliable Insights into whether Missense Variants Are Disease Associated?预测蛋白质 3D 结构能否为错义变异是否与疾病相关提供可靠的见解?
J Mol Biol. 2019 May 17;431(11):2197-2212. doi: 10.1016/j.jmb.2019.04.009. Epub 2019 Apr 14.
4
T-cell and B-cell perturbations identify distinct differences in HIV-2 compared with HIV-1-induced immunodeficiency.T 细胞和 B 细胞的紊乱情况表明,与 HIV-1 引起的免疫缺陷相比,HIV-2 存在明显的差异。
AIDS. 2019 Jun 1;33(7):1131-1141. doi: 10.1097/QAD.0000000000002184.
5
Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study.几内亚比绍与HIV-2相关的艾滋病及死亡率的长期随访:一项前瞻性开放队列研究。
Lancet HIV. 2018 Nov 1. doi: 10.1016/S2352-3018(18)30254-6.
6
90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2.HIV-2 的 90-90-90 目标?通过加强对 HIV-2 感染者的关怀和临床管理来终结 HIV-2 疫情。
Lancet HIV. 2018 Jul;5(7):e390-e399. doi: 10.1016/S2352-3018(18)30094-8.
7
A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.一种用于确定HIV-2共受体使用情况的基因分型方法可用于流行病学研究和临床决策支持。
Retrovirology. 2016 Dec 20;13(1):85. doi: 10.1186/s12977-016-0320-7.
8
Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1.广泛中和抗体与HIV-1的gp120糖蛋白之间相对结合自由能的自由能微扰计算
J Mol Biol. 2017 Apr 7;429(7):930-947. doi: 10.1016/j.jmb.2016.11.021. Epub 2016 Nov 28.
9
Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.CD4模拟化合物对原代人免疫缺陷病毒包膜糖蛋白三聚体的激活与失活作用
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01880-16. Print 2017 Feb 1.
10
A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.一种对1型人类免疫缺陷病毒(HIV-1)、HIV-2和猴免疫缺陷病毒具有高效活性的螺旋短肽融合抑制剂。
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01839-16. Print 2017 Jan 1.